167 related articles for article (PubMed ID: 38374190)
1. Arginase-induced cell death pathways and metabolic changes in cancer cells are not altered by insulin.
Chew HY; Cvetkovic G; Tepic S; Wells JW
Sci Rep; 2024 Feb; 14(1):4112. PubMed ID: 38374190
[TBL] [Abstract][Full Text] [Related]
2. Remission of hepatocellular carcinoma with arginine depletion induced by systemic release of endogenous hepatic arginase due to transhepatic arterial embolisation, augmented by high-dose insulin: arginase as a potential drug candidate for hepatocellular carcinoma.
Cheng PN; Leung YC; Lo WH; Tsui SM; Lam KC
Cancer Lett; 2005 Jun; 224(1):67-80. PubMed ID: 15911102
[TBL] [Abstract][Full Text] [Related]
3. Arginine depriving enzymes: applications as emerging therapeutics in cancer treatment.
Kumari N; Bansal S
Cancer Chemother Pharmacol; 2021 Oct; 88(4):565-594. PubMed ID: 34309734
[TBL] [Abstract][Full Text] [Related]
4. Cancer cell sensitivity to arginine deprivation in vitro is not determined by endogenous levels of arginine metabolic enzymes.
Bobak YP; Vynnytska BO; Kurlishchuk YV; Sibirny AA; Stasyk OV
Cell Biol Int; 2010 Nov; 34(11):1085-9. PubMed ID: 20653567
[TBL] [Abstract][Full Text] [Related]
5. Arginine deprivation in cancer therapy.
Feun LG; Kuo MT; Savaraj N
Curr Opin Clin Nutr Metab Care; 2015 Jan; 18(1):78-82. PubMed ID: 25474015
[TBL] [Abstract][Full Text] [Related]
6. Synergistic therapeutic potential of dexamethasone and L-arginine in lipopolysaccharide-induced septic shock.
Chatterjee S; Premachandran S; Shukla J; Poduval TB
J Surg Res; 2007 Jun; 140(1):99-108. PubMed ID: 17292408
[TBL] [Abstract][Full Text] [Related]
7. L-arginase from Streptomyces diastaticus MAM5 as a potential therapeutic agent in breast cancer: Purification, characterization, G1 phase arrest and autophagy induction.
Hassabo AA; Abdelraof M; Allam RM
Int J Biol Macromol; 2023 Jan; 224():634-645. PubMed ID: 36302487
[TBL] [Abstract][Full Text] [Related]
8. Arginase-II induces vascular smooth muscle cell senescence and apoptosis through p66Shc and p53 independently of its l-arginine ureahydrolase activity: implications for atherosclerotic plaque vulnerability.
Xiong Y; Yu Y; Montani JP; Yang Z; Ming XF
J Am Heart Assoc; 2013 Jul; 2(4):e000096. PubMed ID: 23832324
[TBL] [Abstract][Full Text] [Related]
9. Targeted cellular metabolism for cancer chemotherapy with recombinant arginine-degrading enzymes.
Kuo MT; Savaraj N; Feun LG
Oncotarget; 2010 Aug; 1(4):246-51. PubMed ID: 21152246
[TBL] [Abstract][Full Text] [Related]
10. Effect of arginase II on L-arginine depletion and cell growth in murine cell lines of renal cell carcinoma.
Tate DJ; Vonderhaar DJ; Caldas YA; Metoyer T; Patterson JR; Aviles DH; Zea AH
J Hematol Oncol; 2008 Sep; 1():14. PubMed ID: 18817562
[TBL] [Abstract][Full Text] [Related]
11. Arginine degradation by arginase in mitochondria of soybean seedling cotyledons.
Goldraij A; Polacco JC
Planta; 2000 Mar; 210(4):652-8. PubMed ID: 10787060
[TBL] [Abstract][Full Text] [Related]
12. The effects of oral arginine on its metabolic pathways in Sprague-Dawley rats.
Martin S; Desai K
Br J Nutr; 2020 Jan; 123(2):135-148. PubMed ID: 31647043
[TBL] [Abstract][Full Text] [Related]
13. Human recombinant arginase I [HuArgI (Co)-PEG5000]-induced arginine depletion inhibits ovarian cancer cell adhesion and migration through autophagy-mediated inhibition of RhoA.
El-Mais N; Fakhoury I; Abdellatef S; Abi-Habib R; El-Sibai M
J Ovarian Res; 2021 Jan; 14(1):13. PubMed ID: 33423701
[TBL] [Abstract][Full Text] [Related]
14. Arginase activity in human breast cancer cell lines: N(omega)-hydroxy-L-arginine selectively inhibits cell proliferation and induces apoptosis in MDA-MB-468 cells.
Singh R; Pervin S; Karimi A; Cederbaum S; Chaudhuri G
Cancer Res; 2000 Jun; 60(12):3305-12. PubMed ID: 10866325
[TBL] [Abstract][Full Text] [Related]
15. Liver arginase activity and urea metabolism in beef heifers fed urea diets and abomasally infused with arginine and(or) ammonium acetate.
Koenig JM; Bradley NW; Boling JA
J Anim Sci; 1982 Feb; 54(2):426-33. PubMed ID: 7076598
[TBL] [Abstract][Full Text] [Related]
16. Pegylated arginase I: a potential therapeutic approach in T-ALL.
Hernandez CP; Morrow K; Lopez-Barcons LA; Zabaleta J; Sierra R; Velasco C; Cole J; Rodriguez PC
Blood; 2010 Jun; 115(25):5214-21. PubMed ID: 20407034
[TBL] [Abstract][Full Text] [Related]
17. Myeloid-derived suppressor cells reveal radioprotective properties through arginase-induced l-arginine depletion.
Leonard W; Dufait I; Schwarze JK; Law K; Engels B; Jiang H; Van den Berge D; Gevaert T; Storme G; Verovski V; Breckpot K; De Ridder M
Radiother Oncol; 2016 May; 119(2):291-9. PubMed ID: 26874542
[TBL] [Abstract][Full Text] [Related]
18. Proteomic identification of mitochondrial targets of arginase in human breast cancer.
Singh R; Avliyakulov NK; Braga M; Haykinson MJ; Martinez L; Singh V; Parveen M; Chaudhuri G; Pervin S
PLoS One; 2013; 8(11):e79242. PubMed ID: 24223914
[TBL] [Abstract][Full Text] [Related]
19. l-Arginine depletion blunts antitumor T-cell responses by inducing myeloid-derived suppressor cells.
Fletcher M; Ramirez ME; Sierra RA; Raber P; Thevenot P; Al-Khami AA; Sanchez-Pino D; Hernandez C; Wyczechowska DD; Ochoa AC; Rodriguez PC
Cancer Res; 2015 Jan; 75(2):275-83. PubMed ID: 25406192
[TBL] [Abstract][Full Text] [Related]
20. Arginine enhances glycogen synthesis in response to insulin in 3T3-L1 adipocytes.
Egan JM; Henderson TE; Bernier M
Am J Physiol; 1995 Jul; 269(1 Pt 1):E61-6. PubMed ID: 7631779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
